Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02217891 · ClinicalTrials.gov registry record
IFACT: Incidental Findings in Advanced Cancer Therapy
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 60
- Enrollment target
NCT02217891: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02217891 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02217891 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The proposed study, IFACT - Incidental Findings in Advanced Cancer Therapy, will address this research gap by examining MSK patients' attitudes, preferences, and information needs regarding incidental findings arising from tumor genomic profiling.
Primary Outcome
The study team will review and code the interview transcripts through a process of independent and collaborative thematic content analysis,(25-28) using ATLAS.ti (a qualitative data analysis software package) to facilitate the analysis process (29).
Interventions
- BEHAVIORAL Semi-structured interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-08 |
| Est. Completion | 2023-02-09 |
What the finished NCT02217891 record still lists
NCT02217891 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Semi-structured interview is the first listed.
NCT02217891 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02217891 about?
NCT02217891 is a clinical study titled "IFACT: Incidental Findings in Advanced Cancer Therapy". The proposed study, IFACT - Incidental Findings in Advanced Cancer Therapy, will address this research gap by examining MSK patients' attitudes, preferences, and information needs regarding incidental findings arising from tumor genomic profiling.
What is the current status of trial NCT02217891?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2014-08. Estimated completion is 2023-02-09.
What interventions are being tested in trial NCT02217891?
The interventions under investigation include: Semi-structured interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT02217891?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia